Summary
Updated Aug 31, 2026
Matthew L. Posard is Director of Nautilus Biotechnology, Inc. (NAUT). 3 SEC Form 4 filings on record going back to 2025, most recently on 22 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Matthew L. Posard has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Matthew L. Posard go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew L. Posard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AH Equity Partners Bio II, L.L.C. - $11.75M of NAUT open-market activity in the last 12 months
- Sujal M. Patel - $136K of NAUT open-market activity in the last 12 months
- Matthew B. Murphy - $13K of NAUT open-market activity in the last 12 months
- Kentaro Suzuki - $6K of NAUT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Matthew L. Posard?
Matthew L. Posard is a corporate insider, tracked as Director of Nautilus Biotechnology, Inc. (NAUT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew L. Posard submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Matthew L. Posard's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Matthew L. Posard and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial